Molecular biologist Fiona Behan reports on how the CRISPR gene-editing technique can find cancer’s weak points, identifying targets for new drugs.
Molecular biologist Fiona Behan reports on how the CRISPR gene-editing technique can find cancer’s weak points, identifying targets for new drugs.
Comments are closed.